PT  - JOURNAL ARTICLE
AU  - Harris, Jeffrey E.
TI  - Overcoming Reporting Delays Is Critical to Timely Epidemic Monitoring: The Case of COVID-19 in New York City
AID  - 10.1101/2020.08.02.20159418
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.02.20159418
4099  - http://medrxiv.org/content/early/2020/08/04/2020.08.02.20159418.short
4100  - http://medrxiv.org/content/early/2020/08/04/2020.08.02.20159418.full
AB  - During a fast-moving epidemic, timely monitoring of case counts and other key indicators of disease spread is critical to an effective public policy response. We describe a nonparametric statistical method – originally applied to the reporting of AIDS cases in the 1980s – to estimate the distribution of reporting delays of confirmed COVID-19 cases in New York City. During June 21 – August 1, 2020, the estimated mean delay in reporting was 5 days, with 15 percent of cases reported after 10 or more days. Relying upon the estimated reporting-delay distribution, we project COVID-19 incidence during the most recent three weeks as if each case had instead been reported on the same day that the underlying diagnostic test had been performed. The statistical method described here overcomes the problem of reporting delays only at the population level. The method does not eliminate reporting delays at the individual level. That will require improvements in diagnostic technology, test availability, and specimen processing.This study relies exclusively on publicly available, aggregate health data that contain no individual identifiers. The author has no competing interests and no funding sources to declare. This article represents to the sole opinion of its author and does not necessarily represent the opinions of the Massachusetts Institute of Technology, the National Bureau of Economic Research, Eisner Health, or any other organization.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThere are no funding sources to declare.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study relies exclusively on publicly available, aggregate health data that contain no individual identifiers.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesLinks to the underlying data sources are contained in the references. The author will make all other data and calculations available.